Clinical, Regulatory Services
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
130
NCT05392608
SEQUence of Endocrine Therapy in Advanced Luminal Breast Cancer (SEQUEL-Breast)
Phase: Phase 2
Role: Collaborator
Start: Jun 2, 2022
Completion: Mar 31, 2028
Loading map...